Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3948 | 759 | 39.0 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
317 | 3 | HER2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA | 39408 |
3948 | 2 | SPROUTY//LRIG1//MIG 6 | 759 |
23744 | 1 | SPROUTY//SPROUTY2//SPRED | 336 |
27430 | 1 | LRIG1//LRIG3//UROFACIAL SYNDROME | 230 |
29090 | 1 | MIG 6//ACK1//RALT | 193 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SPROUTY | authKW | 1393124 | 8% | 56% | 62 |
2 | LRIG1 | authKW | 1290913 | 5% | 84% | 38 |
3 | MIG 6 | authKW | 764363 | 3% | 100% | 19 |
4 | ACK1 | authKW | 643666 | 3% | 80% | 20 |
5 | SPROUTY2 | authKW | 473274 | 3% | 59% | 20 |
6 | RALT | authKW | 325858 | 1% | 90% | 9 |
7 | LRIG | authKW | 321837 | 1% | 100% | 8 |
8 | LRIG3 | authKW | 321837 | 1% | 100% | 8 |
9 | UROFACIAL SYNDROME | authKW | 296233 | 1% | 82% | 9 |
10 | SPRED | authKW | 268191 | 1% | 67% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 2340 | 29% | 0% | 222 |
2 | Oncology | 1496 | 24% | 0% | 184 |
3 | Biochemistry & Molecular Biology | 1436 | 38% | 0% | 287 |
4 | Developmental Biology | 1199 | 8% | 0% | 63 |
5 | Genetics & Heredity | 620 | 13% | 0% | 99 |
6 | Biophysics | 234 | 7% | 0% | 56 |
7 | Medicine, Research & Experimental | 59 | 4% | 0% | 34 |
8 | Anatomy & Morphology | 31 | 1% | 0% | 8 |
9 | Urology & Nephrology | 26 | 3% | 0% | 19 |
10 | Pathology | 22 | 2% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEW DRUG DEV DISCOVERY | 80459 | 0% | 100% | 2 |
2 | SINO GERMAN NEUROONCOL MOL | 80459 | 0% | 100% | 2 |
3 | UNIV HOSP SAN VINCENTE DE PAUL | 80459 | 0% | 100% | 2 |
4 | COOPERAT PROGRAM MOL GENET CELL BIOL | 72411 | 0% | 60% | 3 |
5 | CELLULAR BIOL NEUROSCI PROF DR E DE ROBERT | 53638 | 0% | 67% | 2 |
6 | SINOGERMAN NEUROONCOL MOL | 53638 | 0% | 67% | 2 |
7 | MOL CELLULAR IMMUNOL | 42006 | 2% | 7% | 16 |
8 | AFFILIATED HOSP XIANG YA MED 3 | 40230 | 0% | 100% | 1 |
9 | AFFILIATED LISHUI HOSPAFFILIATED HOSP 5CENT HOS | 40230 | 0% | 100% | 1 |
10 | AFFILIATED TUMOR HOSP XIANGYA MED | 40230 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GENE EXPRESSION PATTERNS | 2572 | 1% | 1% | 8 |
2 | ONCOGENE | 2101 | 4% | 0% | 31 |
3 | JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES | 1563 | 1% | 0% | 8 |
4 | MOLECULAR CANCER RESEARCH | 1044 | 1% | 0% | 7 |
5 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1007 | 8% | 0% | 64 |
6 | NATO ADVANCED SCIENCE INSTITUTES SERIES, SERIES A, LIFE SCIENCES | 1003 | 0% | 1% | 3 |
7 | NATURE CELL BIOLOGY | 943 | 1% | 0% | 8 |
8 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 492 | 4% | 0% | 30 |
9 | MECHANISMS OF DEVELOPMENT | 454 | 1% | 0% | 6 |
10 | PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS | 403 | 1% | 0% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SPROUTY | 1393124 | 8% | 56% | 62 | Search SPROUTY | Search SPROUTY |
2 | LRIG1 | 1290913 | 5% | 84% | 38 | Search LRIG1 | Search LRIG1 |
3 | MIG 6 | 764363 | 3% | 100% | 19 | Search MIG+6 | Search MIG+6 |
4 | ACK1 | 643666 | 3% | 80% | 20 | Search ACK1 | Search ACK1 |
5 | SPROUTY2 | 473274 | 3% | 59% | 20 | Search SPROUTY2 | Search SPROUTY2 |
6 | RALT | 325858 | 1% | 90% | 9 | Search RALT | Search RALT |
7 | LRIG | 321837 | 1% | 100% | 8 | Search LRIG | Search LRIG |
8 | LRIG3 | 321837 | 1% | 100% | 8 | Search LRIG3 | Search LRIG3 |
9 | UROFACIAL SYNDROME | 296233 | 1% | 82% | 9 | Search UROFACIAL+SYNDROME | Search UROFACIAL+SYNDROME |
10 | SPRED | 268191 | 1% | 67% | 10 | Search SPRED | Search SPRED |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MASOUMI-MOGHADDAM, S , AMINI, A , MORRIS, DL , (2014) THE DEVELOPING STORY OF SPROUTY AND CANCER.CANCER AND METASTASIS REVIEWS. VOL. 33. ISSUE 2-3. P. 695 -720 | 112 | 65% | 22 |
2 | EDWIN, F , ANDERSON, K , YING, CY , PATEL, TB , (2009) INTERMOLECULAR INTERACTIONS OF SPROUTY PROTEINS AND THEIR IMPLICATIONS IN DEVELOPMENT AND DISEASE.MOLECULAR PHARMACOLOGY. VOL. 76. ISSUE 4. P. 679-691 | 82 | 60% | 47 |
3 | LINDQUIST, D , KVARNBRINK, S , HENRIKSSON, R , HEDMAN, H , (2014) LRIG AND CANCER PROGNOSIS.ACTA ONCOLOGICA. VOL. 53. ISSUE 9. P. 1135 -1142 | 50 | 79% | 6 |
4 | MASON, JM , MORRISON, DJ , BASSON, MA , LICHT, JD , (2006) SPROUTY PROTEINS: MULTIFACETED NEGATIVE-FEED BACK REGULATORS OF RECEPTOR TYROSINE KINASE SIGNALING.TRENDS IN CELL BIOLOGY. VOL. 16. ISSUE 1. P. 45 -54 | 47 | 70% | 252 |
5 | SIMION, C , CEDANO-PRIETO, ME , SWEENEY, C , (2014) THE LRIG FAMILY: ENIGMATIC REGULATORS OF GROWTH FACTOR RECEPTOR SIGNALING.ENDOCRINE-RELATED CANCER. VOL. 21. ISSUE 6. P. R431 -R443 | 50 | 65% | 6 |
6 | MASOUMI-MOGHADDAM, S , AMINI, A , WEI, AQ , ROBERTSON, G , MORRIS, DL , (2015) SPROUTY 2 PROTEIN, BUT NOT SPROUTY 4, IS AN INDEPENDENT PROGNOSTIC BIOMARKER FOR HUMAN EPITHELIAL OVARIAN CANCER.INTERNATIONAL JOURNAL OF CANCER. VOL. 137. ISSUE 3. P. 560 -570 | 39 | 75% | 4 |
7 | KRAL, R , DORIGUZZI, A , MAYER, CE , KRENBEK, D , SETINEK, U , SUTTERLUTY-FALL, H , (2016) DIFFERENTIAL EFFECTS OF VARIATIONS AT CODON 106 ON SPROUTY2 FUNCTIONS IN LUNG CANCER-DERIVED CELLS.JOURNAL OF CELLULAR BIOCHEMISTRY. VOL. 117. ISSUE 8. P. 1822 -1832 | 35 | 85% | 0 |
8 | RATHMANNER, N , HAIGL, B , VANAS, V , DORIGUZZI, A , GSUR, A , SUTTERLUTY-FALL, H , (2013) SPROUTY2 BUT NOT SPROUTY4 IS A POTENT INHIBITOR OF CELL PROLIFERATION AND MIGRATION OF OSTEOSARCOMA CELLS.FEBS LETTERS. VOL. 587. ISSUE 16. P. 2597-2605 | 35 | 83% | 9 |
9 | CABRITA, MA , CHRISTOFORI, G , (2008) SPROUTY PROTEINS, MASTERMINDS OF RECEPTOR TYROSINE KINASE SIGNALING.ANGIOGENESIS. VOL. 11. ISSUE 1. P. 53-62 | 50 | 53% | 125 |
10 | DORIGUZZI, A , SALHI, J , SUTTERLUTY-FALL, H , (2016) SPROUTY4 MRNA VARIANTS AND PROTEIN EXPRESSIONS IN BREAST AND LUNG-DERIVED CELLS.ONCOLOGY LETTERS. VOL. 12. ISSUE 5. P. 4161 -4166 | 32 | 84% | 0 |
Classes with closest relation at Level 2 |